Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.68 |
| ▸ | NOX1 | Q9Y5S8 | 5/20 | 0.65 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.65 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.65 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.65 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.65 |
| ▸ | HTR2C | P28335 | 2/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.65 |
| ▸ | DRD3 | P35462 | 2/20 | 0.65 |
| ▸ | HTR2B | P41595 | 2/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.52 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.52 |
| ▸ | ITGAL | P20701 | 1/20 | 0.52 |
| ▸ | SNCA | P37840 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL628328 | 0.89 | MAOA (0.68) | MAOANOX1ADRA2AADRA2BADRA2C | |
| SCHEMBL12626152 | 0.87 | NOX1 (0.49) | MAOANOX1ADRA2AADRA2BADRA2C | |
| SCHEMBL231247 | 0.82 | MAOA (1.00) | MAOANOX1ADRA2AADRA2BADRA2C | |
| SCHEMBL29377505 | 0.82 | MAOA (1.00) | MAOANOX1ADRA2AADRA2BADRA2C | |
| SCHEMBL4710452 | 0.82 | NOX1 (0.44) | MAOANOX1ADRA2AADRA2BADRA2C | |
| SCHEMBL7170967 | 0.81 | MAOA (0.73) | MAOANOX1ADRA2AADRA2BADRA2C | |
| SCHEMBL628426 | 0.81 | ITGB2 (0.56) | ADRA2AADRA2BADRA2CCHRM3SLC6A2 | |
| SCHEMBL628765 | 0.80 | MAOA (0.70) | MAOANOX1ADRA2AADRA2BADRA2C | |
| SCHEMBL13832958 | 0.79 | BCHE (0.51) | ADRA2AADRA2BADRA2CCHRM3SLC6A2 | |
| SCHEMBL628732 | 0.79 | NOX1 (1.00) | MAOANOX1ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060263697-A1 | Substituted phenothiazine redox shuttles for rechargeable lithium-ion cell | 3M INNOVATIVE PROPERTIES COMPANY | 2006-11-23 | — | — | US | claimed |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2025-06-17 | — | — | US | disclosed |
| US-20240136585-A1 | ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS | APPLE INC. (US) | 2024-04-25 | — | — | US | disclosed |
| US-11881558-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2024-01-23 | — | — | US | disclosed |
| CN-116914244-A | High concentration lithium ion electrolyte for battery cells | 苹果公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20230335785-A1 | HIGH-CONCENTRATION LITHIUM-ION ELECTROLYTES FOR BATTERY CELLS | APPLE INC. (US) | 2023-10-19 | — | — | US | disclosed |
| US-20210218061-A1 | ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS | APPLE INC. (US) | 2021-07-15 | — | — | US | disclosed |
| EP-1883987-B1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES CO (US) | 2012-02-22 | — | — | EP | disclosed |
| US-7615312-B2 | Electrolytic cells; phenothiazine compound has oxidation potential above positive electrode recharged potential and serves as cyclable redox chemical shuttle providing cell overcharge protection | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-11-10 | — | — | US | disclosed |
| EP-1883987-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M Innovative Properties Company (US) | 2008-02-06 | — | — | EP | disclosed |
| US-20060263697-A1 | Substituted phenothiazine redox shuttles for rechargeable lithium-ion cell | 3M INNOVATIVE PROPERTIES COMPANY | 2006-11-23 | — | — | US | disclosed |
| WO-2006124738-A1 | SUBSTITUTED PHENOTHIAZINE REDOX SHUTTLES FOR RECHARGEABLE LITHIUM-ION CELL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210218061-A1 | ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS | CEL, CA3, SLC9B2 | MAOA 3285/4885NOX1 4571/4885ADRA2A 4563/4885 |
| US-20240136585-A1 | ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS | CEL, CA3, SLC9B2 | MAOA 3285/4885NOX1 4571/4885ADRA2A 4563/4885 |
| US-11881558-B2 | Electrolytes for lithium-containing battery cells | CEL, CA3, SLC9B2 | MAOA 3285/4885NOX1 4571/4885ADRA2A 4563/4885 |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | CEL, CA3, SLC9B2 | MAOA 3285/4885NOX1 4571/4885ADRA2A 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.